‘AI lowers the capital needed’: India’s drug discovery push faces test of human trials

AI Summary

Indian scientists and biopharmaceutical companies are using AI to identify potential drug candidates more quickly and at lower cost. Experts caution that AI cannot eliminate the lengthy, expensive, and risky process of testing medicines in human trials.

Indian scientists and biopharmaceutical firms are using artificial intelligence to identify promising drug candidates faster and at lower cost. But industry experts tell CNA the technology can address only part of a lengthy and risky development process.